We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Pfizer’s investigational antiviral for treating COVID-19 at home at the first onset of symptoms could become available by the end of this year, said the company’s CEO Albert Bourla. Read More
AstraZeneca and Sanofi said an ongoing phase 3 study has shown that their investigational antibody, nirsevimab, can prevent respiratory syncytial virus (RSV) infections in infants. Read More
Bristol Myers Squibb (BMS) has reported positive findings from two late-stage clinical trials of deucravacitinib, its experimental treatment for moderate-to-severe plaque psoriasis. Read More
Syndax Pharmaceuticals announced that its targeted cancer therapy, SNDX-5613, induced complete remission for certain advanced leukemia patients in an early-stage study. Read More